Adam Mendelsohn - Aug 30, 2022 Form 4 Insider Report for Vivani Medical, Inc. (VANI)

Role
CEO, Director
Signature
/s/ Adam Mendelsohn
Stock symbol
VANI
Transactions as of
Aug 30, 2022
Transactions value $
$0
Form type
4
Date filed
8/31/2022, 06:43 PM
Next filing
Jan 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VANI Common Stock Other $0 +3.62M $0.00 3.62M Aug 30, 2022 Direct F1
transaction VANI Common Stock Other $0 +90.6K $0.00 90.6K Aug 30, 2022 Trusts F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VANI Common Stock Option Other $0 +60.4K $0.00 60.4K Aug 30, 2022 Common Stock 60.4K $3.15 Direct F3, F4
transaction VANI Warrant Other $0 +31.8K $0.00 31.8K Aug 30, 2022 Common Stock 31.8K $3.15 Direct F5
transaction VANI Warrant Other $0 +4.59K $0.00 4.59K Aug 30, 2022 Common Stock 4.59K $3.15 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical Inc. consummated August 30, 2022.
F2 Represents shares of common stock held by three trusts for the benefit of the children of the Reporting Person, over which the Reporting Person and his spouse have joint voting and diapositive authority. The Reporting Person disclaims pecuniary ownership in the shares of common stock held by the three trusts. Excludes 77,331 shares of common stock held by MFE, LLC in which the Reporting Person has a 10% ownership interest and therefore a pecuniary interest in such shares, but over which the Reporting Person does not have any voting or diapositive authority.
F3 Represents the replacement option to be issued by Vivani Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022.
F4 The option vests 1/48 per month over the four years after the date of grant commencing on December 12, 2018, and the balance thereafter vests in full on the fifth anniversary of the date of grant.
F5 Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision Medical, Inc., consummated on August 30, 2022 pursuant to the Agreement and Plan of Merger dated February 4, 2022.